CN103998057A - 利用CotH的毛霉菌病的免疫疗法和诊断 - Google Patents

利用CotH的毛霉菌病的免疫疗法和诊断 Download PDF

Info

Publication number
CN103998057A
CN103998057A CN201280056226.2A CN201280056226A CN103998057A CN 103998057 A CN103998057 A CN 103998057A CN 201280056226 A CN201280056226 A CN 201280056226A CN 103998057 A CN103998057 A CN 103998057A
Authority
CN
China
Prior art keywords
coth
nucleic acid
polypeptide
seq
oryzae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280056226.2A
Other languages
English (en)
Chinese (zh)
Inventor
A·S·伊布拉伊姆
明福·刘
泰克勒吉奥吉斯·格布雷马里亚姆
跃·付
J·E·爱德华兹
斯科特·菲勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOS ANGELES BIOMEDICAL RES INS
Original Assignee
LOS ANGELES BIOMEDICAL RES INS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOS ANGELES BIOMEDICAL RES INS filed Critical LOS ANGELES BIOMEDICAL RES INS
Publication of CN103998057A publication Critical patent/CN103998057A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201280056226.2A 2011-09-15 2012-09-14 利用CotH的毛霉菌病的免疫疗法和诊断 Pending CN103998057A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161535257P 2011-09-15 2011-09-15
US61/535,257 2011-09-15
PCT/US2012/055659 WO2013040517A2 (en) 2011-09-15 2012-09-14 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH

Publications (1)

Publication Number Publication Date
CN103998057A true CN103998057A (zh) 2014-08-20

Family

ID=47884011

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280056226.2A Pending CN103998057A (zh) 2011-09-15 2012-09-14 利用CotH的毛霉菌病的免疫疗法和诊断

Country Status (7)

Country Link
US (3) US9279002B2 (enExample)
EP (1) EP2755681B1 (enExample)
JP (1) JP2014528715A (enExample)
CN (1) CN103998057A (enExample)
AU (1) AU2012308240A1 (enExample)
CA (1) CA2848765A1 (enExample)
WO (1) WO2013040517A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114324896A (zh) * 2021-12-31 2022-04-12 菲鹏生物股份有限公司 特异性结合mucoricin蛋白的试剂的用途和毛霉菌检测试剂盒

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10465233B2 (en) * 2016-03-25 2019-11-05 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Time-resolved nucleic acid hybridization beacons
EP3454944B1 (en) * 2016-05-13 2022-07-13 The Brigham and Women's Hospital, Inc. Volatile metabolite profiles for the diagnosis and treatment of mucorales fungi
US10877037B2 (en) 2016-11-21 2020-12-29 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Fungal toxins and methods related to the same
WO2022236145A1 (en) * 2021-05-06 2022-11-10 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Coth3 binding agents and uses thereof
CN114568490B (zh) * 2022-04-01 2023-12-19 眉山职业技术学院(眉山技师学院) 雷帕霉素在抑制柑橘青霉菌生长中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405712A (en) 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4493795A (en) 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
JP2561478B2 (ja) 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
JP2914692B2 (ja) 1987-12-11 1999-07-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 内皮細胞の遺伝子修飾
WO1990006997A1 (en) 1988-12-13 1990-06-28 United States Government As Represented By The Secretary Of The Department Of Health And Human Services Genetically engineered endothelial cells and use thereof
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
JPH06500923A (ja) 1990-09-21 1994-01-27 カイロン　コーポレイション パッケージング細胞
WO1992007573A1 (en) 1990-10-31 1992-05-14 Somatix Therapy Corporation Genetic modification of endothelial cells
JP3547129B2 (ja) 1991-02-19 2004-07-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 変更宿主域を有するウィルス粒子
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US7914799B2 (en) * 2001-08-27 2011-03-29 Immunitor USA, Inc. Anti-fungal composition
GB0205378D0 (en) * 2002-03-07 2002-04-24 Royal Holloway University Of L Bacterial spores
EP2049669A2 (en) * 2006-08-09 2009-04-22 DSMIP Assets B.V. Spore surface displays of bioactive molecules
US8697374B2 (en) * 2008-02-28 2014-04-15 3M Innovative Properties Company Antibodies to Clostridium difficile spores and uses thereof
NZ614255A (en) * 2009-03-19 2015-03-27 Los Angeles Biomed Res Inst Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
US20110059111A1 (en) * 2009-09-01 2011-03-10 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Mammalian receptors as targets for antibody and active vaccination therapy against mold infections

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LANDER E. ET.AL: "EIE87171.1", 《GENBANK》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114324896A (zh) * 2021-12-31 2022-04-12 菲鹏生物股份有限公司 特异性结合mucoricin蛋白的试剂的用途和毛霉菌检测试剂盒

Also Published As

Publication number Publication date
JP2014528715A (ja) 2014-10-30
US9279002B2 (en) 2016-03-08
EP2755681A2 (en) 2014-07-23
AU2012308240A1 (en) 2013-05-02
EP2755681A4 (en) 2015-05-13
US20190194301A1 (en) 2019-06-27
WO2013040517A3 (en) 2013-07-18
US20130108642A1 (en) 2013-05-02
WO2013040517A2 (en) 2013-03-21
US20160159887A1 (en) 2016-06-09
CA2848765A1 (en) 2013-03-21
EP2755681B1 (en) 2018-06-27

Similar Documents

Publication Publication Date Title
US20190194301A1 (en) Immunotherapy and diagnosis of mucormycosis using coth
US10300120B2 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
JP2009148287A (ja) 樹状細胞のレセプター
JP2003504062A (ja) 抗原性髄膜炎菌性ペプチド
US20160130330A1 (en) Mammalian receptors as targets for antibody and active vaccination therapy against mold infections
US8216593B2 (en) Parasite vaccine
CN102639557A (zh) 用于治疗毛霉菌病和其它真菌性疾病的疫苗组合物和方法
AU2006244401B2 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US20020034751A1 (en) Aspergillus fumigatus antigenic protein 1
WO2003018629A1 (en) Cage antigen
CN1948335B (zh) 白念珠菌菌丝调控因子基因及其用途
US20030092083A1 (en) Cage antigen
JP2000500326A (ja) フィブロネクチン結合タンパク質ｂ化合物
CN1951966A (zh) 锌指蛋白hzf1抗体
JPH11235182A (ja) 新規化合物
CN106699892A (zh) 肺鳞癌中dnah5融合基因及其用途
JPH10290693A (ja) 新規フィブロネクチン結合蛋白化合物
AU2013203750A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
CN103059110A (zh) 白念珠菌细胞凋亡促进因子基因及其用途
AU2012216520A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
JP2005021166A (ja) 抗原タンパク質及び該タンパク質をコードする核酸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140820